<?xml version="1.0" encoding="UTF-8"?>
<p id="Par56">We here report 1-year safety and preliminary efficacy results of the transcatheter intramyocardial injection of ATMP-CD133 in RA patients with LV dysfunction and concomitant heart failure (HF) and the correlation with myocardial perfusion outcome with CD133
 <sup>+</sup> cell function.
</p>
